Moving Toward Expanded Precision Treatment Of Her2 Or Her3 Driven Breast Gi Lung Other Cancers Peerview Oncology Mp3 & Mp4 Download

51:24

her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors

1:02:48

expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more

1:01:07

protocols for her2-expressing gi cancers: refining btc and gea care with targeted agents

1:38:56

taking aim at gi cancers with personalized her2 and other molecularly targeted therapies

58:30

the potential of her2-, her3-, and trop2-targeted therapies to address unmet needs in advanced nsclc

56:23

are you prepared for the new wave of adcs in nsclc? targeting her2, her3, trop2, and others

57:18

navigating the expanding treatment arsenal for er /her2- breast cancer

1:27:49

biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors

54:02

navigating shifts in the treatment landscape for metastatic her2-positive breast cancer

1:20:02

her2-low expression in breast cancer: opportunities for expanding treatment benefit to more patients

1:18:52

her2-positive gastrointestinal cancers: new evidence and practical guidance with targeted agents

1:16:56

navigating the integration of trop2-targeted therapy in tnbc and hr , her2- breast cancer

1:09:24

raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors

58:27

addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies

1:35:31

leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer

1:29:20

experts discuss antibody-drug conjugates in breast, lung, & gi cancers - https://bit.ly/3rkkvzm

51:40

trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal

1:03:59

selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer

59:18

moving toward expanded precision treatment of her2- or her3-driven breast, gi, lung & other cancers

Download video MP4

Download video MP3

Similar videos

her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors

expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more

protocols for her2-expressing gi cancers: refining btc and gea care with targeted agents

taking aim at gi cancers with personalized her2 and other molecularly targeted therapies

the potential of her2-, her3-, and trop2-targeted therapies to address unmet needs in advanced nsclc

are you prepared for the new wave of adcs in nsclc? targeting her2, her3, trop2, and others

navigating the expanding treatment arsenal for er /her2- breast cancer

biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors

navigating shifts in the treatment landscape for metastatic her2-positive breast cancer

her2-low expression in breast cancer: opportunities for expanding treatment benefit to more patients

her2-positive gastrointestinal cancers: new evidence and practical guidance with targeted agents

navigating the integration of trop2-targeted therapy in tnbc and hr , her2- breast cancer

raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors

addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies

leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer

experts discuss antibody-drug conjugates in breast, lung, & gi cancers - https://bit.ly/3rkkvzm

trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal

selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer

optimizing novel her2-targeted therapies and other agents in gastric cancer care